{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:01:25Z","timestamp":1790870485150,"version":"4.1.0"},"reference-count":173,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,29]],"date-time":"2024-12-29T00:00:00Z","timestamp":1735430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,29]],"date-time":"2024-12-29T00:00:00Z","timestamp":1735430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Liaocheng Key Research and Development Plan","award":["2022YDSF26"],"award-info":[{"award-number":["2022YDSF26"]}]},{"name":"Shandong Society of Geriatrics Scientific and Technological Research Project","award":["LKJGG2021W067"],"award-info":[{"award-number":["LKJGG2021W067"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuromol Med"],"DOI":"10.1007\/s12017-024-08815-z","type":"journal-article","created":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T23:15:09Z","timestamp":1735859709000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["The Interplay Between Accumulation of Amyloid-Beta and Tau Proteins, PANoptosis, and Inflammation in Alzheimer\u2019s Disease"],"prefix":"10.1007","volume":"27","author":[{"given":"Xianbo","family":"Zhuang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru","family":"Ban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangyong","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guifeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,29]]},"reference":[{"key":"8815_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.595532","volume":"11","author":"C Alquezar","year":"2020","unstructured":"Alquezar, C., Arya, S., & Kao, A. W. (2020). Tau post-translational modifications: Dynamic transformers of tau function, degradation, and aggregation. Frontiers in Neurology, 11, 595532.","journal-title":"Frontiers in Neurology"},{"issue":"1","key":"8815_CR2","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s41983-024-00845-5","volume":"60","author":"TB Ameen","year":"2024","unstructured":"Ameen, T. B., Kashif, S. N., Abbas, S. M. I., Babar, K., Ali, S. M. S., & Raheem, A. (2024). Unraveling Alzheimer\u2019s: The promise of aducanumab, lecanemab, and donanemab. The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 60(1), 72.","journal-title":"The Egyptian Journal of Neurology, Psychiatry and Neurosurgery"},{"issue":"1","key":"8815_CR3","doi-asserted-by":"publisher","first-page":"6412","DOI":"10.1038\/s41598-018-24501-0","volume":"8","author":"JW Arndt","year":"2018","unstructured":"Arndt, J. W., Qian, F., Smith, B. A., Quan, C., Kilambi, K. P., Bush, M. W., Walz, T., Pepinsky, R. B., Bussi\u00e8re, T., Hamann, S., Cameron, T. O., & Weinreb, P. H. (2018). Structural and kinetic basis for the selectivity of aducanumab for aggregated forms of amyloid-\u03b2. Science and Reports, 8(1), 6412.","journal-title":"Science and Reports"},{"key":"8815_CR4","doi-asserted-by":"crossref","unstructured":"Ashton, N. J., Janelidze, S., Mattsson-Carlgren, N., Binette, A. P., Strandberg, O., Brum, W. S., Karikari, T. K., Gonz\u00e1lez-Ortiz, F., Di Molfetta, G., Meda, F. J., Jonaitis, E. M., Koscik, R. L., Cody, K., Betthauser, T. J., Li, Y., Vanmechelen, E., Palmqvist, S., Stomrud, E., Bateman, R. J., \u2026, Hansson, O. (2022). Differential roles of A\u03b242\/40, p-tau231 and p-tau217 for Alzheimer\u2019s trial selection and disease monitoring. Nature Medicine, 28(12), 2555\u20132562.","DOI":"10.1038\/s41591-022-02074-w"},{"issue":"43","key":"8815_CR5","doi-asserted-by":"publisher","first-page":"26043","DOI":"10.1074\/jbc.M115.679043","volume":"290","author":"Y Atagi","year":"2015","unstructured":"Atagi, Y., Liu, C.-C., Painter, M. M., Chen, X.-F., Verbeeck, C., Zheng, H., Li, X., Rademakers, R., Kang, S. S., Xu, H., Younkin, S., Das, P., Fryer, J. D., & Bu, G. (2015). Apolipoprotein E is a ligand for triggering receptor expressed on myeloid cells 2 (TREM2). Journal of Biological Chemistry, 290(43), 26043\u201326050.","journal-title":"Journal of Biological Chemistry"},{"issue":"7","key":"8815_CR6","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s12272-024-01506-0","volume":"47","author":"H Bae","year":"2024","unstructured":"Bae, H., Jang, Y., Karki, R., & Han, J.-H. (2024). Implications of inflammatory cell death-PANoptosis in health and disease. Archives of Pharmacal Research, 47(7), 617\u2013631.","journal-title":"Archives of Pharmacal Research"},{"issue":"1","key":"8815_CR7","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s00401-024-02747-5","volume":"147","author":"S Balusu","year":"2024","unstructured":"Balusu, S., & De Strooper, B. (2024). The necroptosis cell death pathway drives neurodegeneration in Alzheimer\u2019s disease. Acta Neuropathologica, 147(1), 96.","journal-title":"Acta Neuropathologica"},{"key":"8815_CR8","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3389\/fnagi.2019.00204","volume":"11","author":"P Barbier","year":"2019","unstructured":"Barbier, P., Zejneli, O., Martinho, M., Lasorsa, A., Belle, V., Smet-Nocca, C., Tsvetkov, P. O., Devred, F., & Landrieu, I. (2019). Role of tau as a microtubule-associated protein: Structural and functional aspects. Frontiers in Aging Neuroscience, 11, 204.","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"5","key":"8815_CR9","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1038\/s41423-020-00630-3","volume":"18","author":"D Bertheloot","year":"2021","unstructured":"Bertheloot, D., Latz, E., & Franklin, B. S. (2021). Necroptosis, pyroptosis and apoptosis: An intricate game of cell death. Cellular & Molecular Immunology, 18(5), 1106\u20131121.","journal-title":"Cellular & Molecular Immunology"},{"issue":"11","key":"8815_CR10","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41582-021-00549-x","volume":"17","author":"BM Bettcher","year":"2021","unstructured":"Bettcher, B. M., Tansey, M. G., Doroth\u00e9e, G., & Heneka, M. T. (2021). Peripheral and central immune system crosstalk in Alzheimer disease\u2014A research prospectus. Nature Reviews Neurology, 17(11), 689\u2013701.","journal-title":"Nature Reviews Neurology"},{"issue":"4","key":"8815_CR11","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","volume":"71","author":"GS Bloom","year":"2014","unstructured":"Bloom, G. S. (2014). Amyloid-\u03b2 and tau: The trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurology, 71(4), 505\u2013508.","journal-title":"JAMA Neurology"},{"issue":"1","key":"8815_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00401-024-02790-2","volume":"148","author":"P Botella Lucena","year":"2024","unstructured":"Botella Lucena, P., & Heneka, M. T. (2024). Inflammatory aspects of Alzheimer\u2019s disease. Acta Neuropathologica, 148(1), 31.","journal-title":"Acta Neuropathologica"},{"issue":"4","key":"8815_CR13","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak, H., & Braak, E. (1991). Neuropathological stageing of Alzheimer-related changes. Acta Neuropathologica, 82(4), 239\u2013259.","journal-title":"Acta Neuropathologica"},{"issue":"11","key":"8815_CR14","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1097\/NEN.0b013e318232a379","volume":"70","author":"H Braak","year":"2011","unstructured":"Braak, H., Thal, D. R., Ghebremedhin, E., & Del Tredici, K. (2011). Stages of the pathologic process in Alzheimer disease: Age categories from 1 to 100 years. Journal of Neuropathology and Experimental Neurology, 70(11), 960\u2013969.","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"issue":"9","key":"8815_CR15","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/nn.4608","volume":"20","author":"A Caccamo","year":"2017","unstructured":"Caccamo, A., Branca, C., Piras, I. S., Ferreira, E., Huentelman, M. J., Liang, W. S., Readhead, B., Dudley, J. T., Spangenberg, E. E., Green, K. N., Belfiore, R., Winslow, W., & Oddo, S. (2017). Necroptosis activation in Alzheimer\u2019s disease. Nature Neuroscience, 20(9), 1236\u20131246.","journal-title":"Nature Neuroscience"},{"issue":"5","key":"8815_CR16","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.3892\/mmr.2014.2040","volume":"9","author":"Z Cai","year":"2014","unstructured":"Cai, Z. (2014). Monoamine oxidase inhibitors: Promising therapeutic agents for Alzheimer\u2019s disease (Review). Molecular Medicine Reports, 9(5), 1530\u20131541.","journal-title":"Molecular Medicine Reports"},{"issue":"1","key":"8815_CR17","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13024-024-00702-2","volume":"19","author":"M Calvo-Rodriguez","year":"2024","unstructured":"Calvo-Rodriguez, M., Kharitonova, E. K., Snyder, A. C., Hou, S. S., Sanchez-Mico, M. V., Das, S., Fan, Z., Shirani, H., Nilsson, K. P. R., Serrano-Pozo, A., & Bacskai, B. J. (2024). Real-time imaging of mitochondrial redox reveals increased mitochondrial oxidative stress associated with amyloid \u03b2 aggregates in vivo in a mouse model of Alzheimer\u2019s disease. Molecular Neurodegeneration, 19(1), 6.","journal-title":"Molecular Neurodegeneration"},{"issue":"11","key":"8815_CR18","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1093\/hmg\/ddr100","volume":"20","author":"S Casas-Tinto","year":"2011","unstructured":"Casas-Tinto, S., Zhang, Y., Sanchez-Garcia, J., Gomez-Velazquez, M., Rincon-Limas, D. E., & Fernandez-Funez, P. (2011). The ER stress factor XBP1s prevents amyloid-beta neurotoxicity. Human Molecular Genetics, 20(11), 2144\u20132160.","journal-title":"Human Molecular Genetics"},{"key":"8815_CR19","doi-asserted-by":"crossref","unstructured":"Cattaneo, A., Cattane, N., Galluzzi, S., Provasi, S., Lopizzo, N., Festari, C., Ferrari, C., Guerra, U. P., Paghera, B., Muscio, C., Bianchetti, A., Volta, G. D., Turla, M., Cotelli, M. S., Gennuso, M., Prelle, A., Zanetti, O., Lussignoli, G., Mirabile, D., \u2026, Frisoni, G. B. (2017). Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiology of Aging, 49, 60\u201368.","DOI":"10.1016\/j.neurobiolaging.2016.08.019"},{"issue":"4","key":"8815_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0034929","volume":"7","author":"M-Y Cha","year":"2012","unstructured":"Cha, M.-Y., Han, S.-H., Son, S. M., Hong, H.-S., Choi, Y.-J., Byun, J., & Mook-Jung, I. (2012). Mitochondria-specific accumulation of amyloid \u03b2 induces mitochondrial dysfunction leading to apoptotic cell death. PLoS ONE, 7(4), e34929.","journal-title":"PLoS ONE"},{"key":"8815_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115656","volume":"168","author":"S Chavoshinezhad","year":"2023","unstructured":"Chavoshinezhad, S., Beirami, E., Izadpanah, E., Feligioni, M., & Hassanzadeh, K. (2023). Molecular mechanism and potential therapeutic targets of necroptosis and ferroptosis in Alzheimer\u2019s disease. Biomedicine & Pharmacotherapy, 168, 115656.","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"1","key":"8815_CR22","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12974-020-01853-x","volume":"17","author":"S Chen","year":"2020","unstructured":"Chen, S., Peng, J., Sherchan, P., Ma, Y., Xiang, S., Yan, F., Zhao, H., Jiang, Y., Wang, N., Zhang, J. H., & Zhang, H. (2020). TREM2 activation attenuates neuroinflammation and neuronal apoptosis via PI3K\/Akt pathway after intracerebral hemorrhage in mice. Journal of Neuroinflammation, 17(1), 168.","journal-title":"Journal of Neuroinflammation"},{"issue":"1","key":"8815_CR23","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12974-023-02853-3","volume":"20","author":"Y Chen","year":"2023","unstructured":"Chen, Y., & Yu, Y. (2023). Tau and neuroinflammation in Alzheimer\u2019s disease: Interplay mechanisms and clinical translation. Journal of Neuroinflammation, 20(1), 165.","journal-title":"Journal of Neuroinflammation"},{"issue":"14","key":"8815_CR24","doi-asserted-by":"publisher","first-page":"7952","DOI":"10.3390\/ijms25147952","volume":"25","author":"E-H Choi","year":"2024","unstructured":"Choi, E.-H., Kim, M.-H., & Park, S.-J. (2024). Targeting mitochondrial dysfunction and reactive oxygen species for neurodegenerative disease treatment. International Journal of Molecular Sciences, 25(14), 7952.","journal-title":"International Journal of Molecular Sciences"},{"issue":"14","key":"8815_CR25","doi-asserted-by":"publisher","first-page":"11757","DOI":"10.3390\/ijms241411757","volume":"24","author":"S-B Choi","year":"2023","unstructured":"Choi, S.-B., Kwon, S., Kim, J.-H., Ahn, N.-H., Lee, J.-H., & Yang, S.-H. (2023). The molecular mechanisms of neuroinflammation in Alzheimer\u2019s disease, the consequence of neural cell death. International Journal of Molecular Sciences, 24(14), 11757.","journal-title":"International Journal of Molecular Sciences"},{"issue":"2","key":"8815_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0299577","volume":"19","author":"SM Choudhury","year":"2024","unstructured":"Choudhury, S. M., Sarkar, R., Karki, R., & Kanneganti, T.-D. (2024). A comparative study of apoptosis, pyroptosis, necroptosis, and PANoptosis components in mouse and human cells. PLoS ONE, 19(2), e0299577.","journal-title":"PLoS ONE"},{"issue":"1","key":"8815_CR27","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13024-021-00440-9","volume":"16","author":"K Clayton","year":"2021","unstructured":"Clayton, K., Delpech, J. C., Herron, S., Iwahara, N., Ericsson, M., Saito, T., Saido, T. C., Ikezu, S., & Ikezu, T. (2021). Plaque associated microglia hyper-secrete extracellular vesicles and accelerate tau propagation in a humanized APP mouse model. Molecular Neurodegeneration, 16(1), 18.","journal-title":"Molecular Neurodegeneration"},{"issue":"2","key":"8815_CR28","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1093\/jnen\/64.2.104","volume":"64","author":"CW Cotman","year":"2005","unstructured":"Cotman, C. W., Poon, W. W., Rissman, R. A., & Blurton-Jones, M. (2005). The role of caspase cleavage of tau in Alzheimer disease neuropathology. Journal of Neuropathology and Experimental Neurology, 64(2), 104\u2013112.","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"issue":"5","key":"8815_CR29","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s00401-010-0716-8","volume":"120","author":"CM Cowan","year":"2010","unstructured":"Cowan, C. M., Bossing, T., Page, A., Shepherd, D., & Mudher, A. (2010). Soluble hyper-phosphorylated tau causes microtubule breakdown and functionally compromises normal tau in vivo. Acta Neuropathologica, 120(5), 593\u2013604.","journal-title":"Acta Neuropathologica"},{"key":"8815_CR30","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3389\/fnagi.2020.00265","volume":"12","author":"P d\u2019Errico","year":"2020","unstructured":"d\u2019Errico, P., & Meyer-Luehmann, M. (2020). Mechanisms of pathogenic tau and A\u03b2 protein spreading in Alzheimer\u2019s disease. Frontiers in Aging Neuroscience, 12, 265.","journal-title":"Frontiers in Aging Neuroscience"},{"key":"8815_CR31","doi-asserted-by":"publisher","first-page":"1178662","DOI":"10.3389\/fimmu.2023.1178662","volume":"14","author":"Z Dai","year":"2023","unstructured":"Dai, Z., Liu, W.-C., Chen, X.-Y., Wang, X., Li, J.-L., & Zhang, X. (2023). Gasdermin D-mediated pyroptosis: Mechanisms, diseases, and inhibitors. Frontiers in Immunology, 14, 1178662.","journal-title":"Frontiers in Immunology"},{"issue":"8","key":"8815_CR32","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1038\/s41591-021-01455-x","volume":"27","author":"T Dam","year":"2021","unstructured":"Dam, T., Boxer, A. L., Golbe, L. I., H\u00f6glinger, G. U., Morris, H. R., Litvan, I., Lang, A. E., Corvol, J.-C., Aiba, I., Grundman, M., Yang, L., Tidemann-Miller, B., Kupferman, J., Harper, K., Kamisoglu, K., Wald, M. J., Graham, D. L., Gedney, L., O\u2019Gorman, J., Samantha Budd Haeberlein & PASSPORT Study Group. (2021). Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: A phase 2, randomized, placebo-controlled trial. Nature Medicine, 27(8), 1451\u20131457.","journal-title":"Nature Medicine"},{"issue":"1","key":"8815_CR33","doi-asserted-by":"publisher","first-page":"10092","DOI":"10.1038\/s41598-022-13683-3","volume":"12","author":"M de la Cueva","year":"2022","unstructured":"de la Cueva, M., Antequera, D., Ordo\u00f1ez-Gutierrez, L., Wandosell, F., Camins, A., Carro, E., & Bartolome, F. (2022). Amyloid-\u03b2 impairs mitochondrial dynamics and autophagy in Alzheimer\u2019s disease experimental models. Science and Reports, 12(1), 10092.","journal-title":"Science and Reports"},{"key":"8815_CR34","doi-asserted-by":"crossref","unstructured":"Deming, Y., Filipello, F., Cignarella, F., Cantoni, C., Hsu, S., Mikesell, R., Li, Z., Del-Aguila, J. L., Dube, U., Farias, F. G., Bradley, J., Budde, J., Ibanez, L., Fernandez, M. V., Blennow, K., Zetterberg, H., Heslegrave, A., Johansson, P. M., Svensson, J., \u2026, Cruchaga, C. (2019). The MS4A gene cluster is a key modulator of soluble TREM2 and Alzheimer\u2019s disease risk. Science Translational Medicine, 11(505), eaau2291.","DOI":"10.1126\/scitranslmed.aau2291"},{"issue":"1","key":"8815_CR35","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s00204-023-03628-8","volume":"98","author":"A Dias-Carvalho","year":"2024","unstructured":"Dias-Carvalho, A., S\u00e1, S. I., Carvalho, F., Fernandes, E., & Costa, V. M. (2024). Inflammation as common link to progressive neurological diseases. Archives of Toxicology, 98(1), 95\u2013119.","journal-title":"Archives of Toxicology"},{"issue":"1","key":"8815_CR36","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12974-019-1453-0","volume":"16","author":"DA Dionisio-Santos","year":"2019","unstructured":"Dionisio-Santos, D. A., Olschowka, J. A., & O\u2019Banion, M. K. (2019). Exploiting microglial and peripheral immune cell crosstalk to treat Alzheimer\u2019s disease. Journal of Neuroinflammation, 16(1), 74.","journal-title":"Journal of Neuroinflammation"},{"key":"8815_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101263","volume":"67","author":"PA Dion\u00edsio","year":"2021","unstructured":"Dion\u00edsio, P. A., Amaral, J. D., & Rodrigues, C. M. P. (2021). Oxidative stress and regulated cell death in Parkinson\u2019s disease. Ageing Research Reviews, 67, 101263.","journal-title":"Ageing Research Reviews"},{"key":"8815_CR38","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1742-2094-11-48","volume":"11","author":"D Doens","year":"2014","unstructured":"Doens, D., & Fern\u00e1ndez, P. L. (2014). Microglia receptors and their implications in the response to amyloid \u03b2 for Alzheimer\u2019s disease pathogenesis. Journal of Neuroinflammation, 11, 48.","journal-title":"Journal of Neuroinflammation"},{"issue":"1","key":"8815_CR39","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/2047-9158-1-18","volume":"1","author":"S Dong","year":"2012","unstructured":"Dong, S., Duan, Y., Hu, Y., & Zhao, Z. (2012). Advances in the pathogenesis of Alzheimer\u2019s disease: A re-evaluation of amyloid cascade hypothesis. Transl Neurodegener, 1(1), 18.","journal-title":"Transl Neurodegener"},{"issue":"1","key":"8815_CR40","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12974-022-02567-y","volume":"19","author":"Y Dong","year":"2022","unstructured":"Dong, Y., Yu, H., Li, X., Bian, K., Zheng, Y., Dai, M., Feng, X., Sun, Y., He, Y., Yu, B., Zhang, H., Wu, J., Yu, X., Wu, H., & Kong, W. (2022). Hyperphosphorylated tau mediates neuronal death by inducing necroptosis and inflammation in Alzheimer\u2019s disease. Journal of Neuroinflammation, 19(1), 205.","journal-title":"Journal of Neuroinflammation"},{"issue":"22","key":"8815_CR41","doi-asserted-by":"publisher","first-page":"9066","DOI":"10.1073\/pnas.1219451110","volume":"110","author":"A Everard","year":"2013","unstructured":"Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J. P., Druart, C., Bindels, L. B., Guiot, Y., Derrien, M., Muccioli, G. G., Delzenne, N. M., de Vos, W. M., & Cani, P. D. (2013). Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proceedings of the National Academy of Sciences of the United States of America, 110(22), 9066\u20139071.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"3","key":"8815_CR42","first-page":"792","volume":"140","author":"Z Fan","year":"2017","unstructured":"Fan, Z., Brooks, D. J., Okello, A., & Edison, P. (2017). An early and late peak in microglial activation in Alzheimer\u2019s disease trajectory. Brain, 140(3), 792\u2013803.","journal-title":"Brain"},{"issue":"3","key":"8815_CR43","first-page":"414","volume":"12","author":"T Fernandes","year":"2023","unstructured":"Fernandes, T., Domingues, M. R., Moreira, P. I., & Pereira, C. F. (2023). A perspective on the link between mitochondria-associated membranes (MAMs) and lipid droplets metabolism in neurodegenerative diseases. Biology (Basel), 12(3), 414.","journal-title":"Biology (Basel)"},{"issue":"3","key":"8815_CR44","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.nbd.2006.05.011","volume":"23","author":"E Ferreiro","year":"2006","unstructured":"Ferreiro, E., Resende, R., Costa, R., Oliveira, C. R., Oliveira, C. R., & Pereira, C. M. F. (2006). An endoplasmic-reticulum-specific apoptotic pathway is involved in prion and amyloid-beta peptides neurotoxicity. Neurobiology of Diseases, 23(3), 669\u2013678.","journal-title":"Neurobiology of Diseases"},{"issue":"7","key":"8815_CR45","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/BF03401753","volume":"4","author":"M Fiala","year":"1998","unstructured":"Fiala, M., Zhang, L., Gan, X., Sherry, B., Taub, D., Graves, M. C., Hama, S., Way, D., Weinand, M., Witte, M., Lorton, D., Kuo, Y.-M., & Roher, A. E. (1998). Amyloid-\u03b2 induces chemokine secretion and monocyte migration across a human blood-brain barrier model. Molecular Medicine, 4(7), 480\u2013489.","journal-title":"Molecular Medicine"},{"issue":"11","key":"8815_CR46","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.3390\/biom12111676","volume":"12","author":"Z Fi\u0161ar","year":"2022","unstructured":"Fi\u0161ar, Z. (2022). Linking the amyloid, tau, and mitochondrial hypotheses of Alzheimer\u2019s disease and identifying promising drug targets. Biomolecules, 12(11), 1676.","journal-title":"Biomolecules"},{"issue":"9","key":"8815_CR47","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1212\/01.WNL.0000159740.16984.3C","volume":"64","author":"S Gilman","year":"2005","unstructured":"Gilman, S., Koller, M., Black, R. S., Jenkins, L., Griffith, S. G., Fox, N. C., Eisner, L., Kirby, L., Rovira, M. B., Forette, F., & Orgogozo, J.-M. (2005). Clinical effects of A\u03b2 immunization (AN1792) in patients with AD in an interrupted trial. Neurology, 64(9), 1553\u20131562.","journal-title":"Neurology"},{"key":"8815_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2022.937133","volume":"15","author":"P Goel","year":"2022","unstructured":"Goel, P., Chakrabarti, S., Goel, K., Bhutani, K., Chopra, T., & Bali, S. (2022). Neuronal cell death mechanisms in Alzheimer\u2019s disease: An insight. Frontiers in Molecular Neuroscience, 15, 937133.","journal-title":"Frontiers in Molecular Neuroscience"},{"issue":"1","key":"8815_CR49","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13024-018-0298-9","volume":"13","author":"M Gratuze","year":"2018","unstructured":"Gratuze, M., Leyns, C. E. G., & Holtzman, D. M. (2018). New insights into the role of TREM2 in Alzheimer\u2019s disease. Molecular Neurodegeneration, 13(1), 66.","journal-title":"Molecular Neurodegeneration"},{"issue":"4","key":"8815_CR50","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.neuron.2013.04.014","volume":"78","author":"A Griciuc","year":"2013","unstructured":"Griciuc, A., Serrano-Pozo, A., Parrado, A. R., Lesinski, A. N., Asselin, C. N., Mullin, K., Hooli, B., Choi, S. H., Hyman, B. T., & Tanzi, R. E. (2013). Alzheimer\u2019s disease risk gene CD33 inhibits microglial uptake of amyloid beta. Neuron, 78(4), 631\u2013643.","journal-title":"Neuron"},{"issue":"10","key":"8815_CR51","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s40267-022-00944-4","volume":"38","author":"S Grover","year":"2022","unstructured":"Grover, S., & Jain, S. (2022). Aducanumab: A review of the first approved amyloid-targeting antibody for Alzheimer\u2019s disease. Drugs & Therapy Perspectives, 38(10), 443\u2013454.","journal-title":"Drugs & Therapy Perspectives"},{"issue":"9","key":"8815_CR52","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.3390\/cells11091495","volume":"11","author":"JM Gullett","year":"2022","unstructured":"Gullett, J. M., Tweedell, R. E., & Kanneganti, T.-D. (2022). It\u2019s all in the PAN: Crosstalk, plasticity, redundancies, switches, and interconnectedness encompassed by PANoptosis underlying the totality of cell death-associated biological effects. Cells, 11(9), 1495.","journal-title":"Cells"},{"key":"8815_CR53","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.3389\/fphar.2019.01008","volume":"10","author":"L Guzman-Martinez","year":"2019","unstructured":"Guzman-Martinez, L., Maccioni, R. B., Andrade, V., Navarrete, L. P., Pastor, M. G., & Ramos-Escobar, N. (2019). Neuroinflammation as a common feature of neurodegenerative disorders. Frontiers in Pharmacology, 10, 1008.","journal-title":"Frontiers in Pharmacology"},{"issue":"8","key":"8815_CR54","doi-asserted-by":"publisher","first-page":"3164","DOI":"10.1038\/s41380-022-01637-0","volume":"27","author":"V Haage","year":"2022","unstructured":"Haage, V., & De Jager, P. L. (2022). Neuroimmune contributions to Alzheimer\u2019s disease: A focus on human data. Molecular Psychiatry, 27(8), 3164\u20133181.","journal-title":"Molecular Psychiatry"},{"issue":"4","key":"8815_CR55","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1093\/brain\/aww017","volume":"139","author":"L Hamelin","year":"2016","unstructured":"Hamelin, L., Lagarde, J., Doroth\u00e9e, G., Leroy, C., Labit, M., Comley, R. A., de Souza, L. C., Corne, H., Dauphinot, L., Bertoux, M., Dubois, B., Gervais, P., Colliot, O., Potier, M. C., Bottlaender, M., Sarazin, M., The Clinical IMABio3 team. (2016). Early and protective microglial activation in Alzheimer\u2019s disease: A prospective study using 18F-DPA-714 PET imaging. Brain, 139(4), 1252\u20131264.","journal-title":"Brain"},{"issue":"10","key":"8815_CR56","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","volume":"26","author":"H Hampel","year":"2021","unstructured":"Hampel, H., Hardy, J., Blennow, K., Chen, C., Perry, G., Kim, S. H., Villemagne, V. L., Aisen, P., Vendruscolo, M., Iwatsubo, T., Masters, C. L., Cho, M., Lannfelt, L., Cummings, J. L., & Vergallo, A. (2021). The amyloid-\u03b2 pathway in Alzheimer\u2019s disease. Molecular Psychiatry, 26(10), 5481\u20135503.","journal-title":"Molecular Psychiatry"},{"issue":"3 Suppl","key":"8815_CR57","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3233\/JAD-2006-9S317","volume":"9","author":"J Hardy","year":"2006","unstructured":"Hardy, J. (2006). Alzheimer\u2019s disease: The amyloid cascade hypothesis: An update and reappraisal. Journal of Alzheimer\u2019s Disease, 9(3 Suppl), 151\u2013153.","journal-title":"Journal of Alzheimer's Disease"},{"issue":"5054","key":"8815_CR58","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy, J. A., & Higgins, G. A. (1992). Alzheimer\u2019s disease: The amyloid cascade hypothesis. Science, 256(5054), 184\u2013185.","journal-title":"Science"},{"issue":"19","key":"8815_CR59","doi-asserted-by":"publisher","first-page":"7916","DOI":"10.1073\/pnas.1300677110","volume":"110","author":"L Hedskog","year":"2013","unstructured":"Hedskog, L., Pinho, C. M., Filadi, R., R\u00f6nnb\u00e4ck, A., Hertwig, L., Wiehager, B., Larssen, P., Gellhaar, S., Sandebring, A., Westerlund, M., Graff, C., Winblad, B., Galter, D., Behbahani, H., Pizzo, P., Glaser, E., & Ankarcrona, M. (2013). Modulation of the endoplasmic reticulum\u2013mitochondria interface in Alzheimer\u2019s disease and related models. Proceedings of the National Academy of Sciences of the United States of America, 110(19), 7916\u20137921.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6","key":"8815_CR60","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nrn3880","volume":"16","author":"FL Heppner","year":"2015","unstructured":"Heppner, F. L., Ransohoff, R. M., & Becher, B. (2015). Immune attack: The role of inflammation in Alzheimer disease. Nature Reviews. Neurology, 16(6), 358\u2013372.","journal-title":"Nature Reviews. Neurology"},{"issue":"Suppl 1","key":"8815_CR61","first-page":"S141","volume":"33","author":"F Hernandez","year":"2013","unstructured":"Hernandez, F., Lucas, J. J., & Avila, J. (2013). GSK3 and tau: Two convergence points in Alzheimer\u2019s disease. Journal of Alzheimer\u2019s Disease, 33(Suppl 1), S141\u2013S144.","journal-title":"Journal of Alzheimer's Disease"},{"issue":"7","key":"8815_CR62","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41580-019-0101-y","volume":"20","author":"MS Hipp","year":"2019","unstructured":"Hipp, M. S., Kasturi, P., & Hartl, F. U. (2019). The proteostasis network and its decline in ageing. Nature Reviews Molecular Cell Biology, 20(7), 421\u2013435.","journal-title":"Nature Reviews Molecular Cell Biology"},{"key":"8815_CR63","doi-asserted-by":"crossref","unstructured":"Honig, L. S., Vellas, B., Woodward, M., Boada, M., Bullock, R., Borrie, M., Hager, K., Andreasen, N., Scarpini, E., Liu-Seifert, H., Case, M., Dean, R. A., Hake, A., Sundell, K., Poole Hoffmann, V., Carlson, C., Khanna, R., Mintun, M., DeMattos, R., \u2026, Siemers, E. (2018). Trial of solanezumab for mild dementia due to Alzheimer\u2019s disease. New England Journal of Medicine, 378(4), 321\u2013330.","DOI":"10.1056\/NEJMoa1705971"},{"issue":"6","key":"8815_CR64","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1111\/j.1471-4159.2007.05194.x","volume":"104","author":"C Hooper","year":"2008","unstructured":"Hooper, C., Killick, R., & Lovestone, S. (2008). The GSK3 hypothesis of Alzheimer\u2019s disease. Journal of Neurochemistry, 104(6), 1433\u20131439.","journal-title":"Journal of Neurochemistry"},{"issue":"1","key":"8815_CR65","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13024-022-00588-y","volume":"17","author":"J Hou","year":"2022","unstructured":"Hou, J., Chen, Y., Grajales-Reyes, G., & Colonna, M. (2022). TREM2 dependent and independent functions of microglia in Alzheimer\u2019s disease. Molecular Neurodegeneration, 17(1), 84.","journal-title":"Molecular Neurodegeneration"},{"issue":"3","key":"8815_CR66","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1523\/JNEUROSCI.2110-16.2016","volume":"37","author":"TR Jay","year":"2017","unstructured":"Jay, T. R., Hirsch, A. M., Broihier, M. L., Miller, C. M., Neilson, L. E., Ransohoff, R. M., Lamb, B. T., & Landreth, G. E. (2017). Disease progression-dependent effects of TREM2 deficiency in a mouse model of Alzheimer\u2019s disease. Journal of Neuroscience, 37(3), 637\u2013647.","journal-title":"Journal of Neuroscience"},{"issue":"3","key":"8815_CR67","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1084\/jem.20142322","volume":"212","author":"TR Jay","year":"2015","unstructured":"Jay, T. R., Miller, C. M., Cheng, P. J., Graham, L. C., Bemiller, S., Broihier, M. L., Xu, G., Margevicius, D., Karlo, J. C., Sousa, G. L., Cotleur, A. C., Butovsky, O., Bekris, L., Staugaitis, S. M., Leverenz, J. B., Pimplikar, S. W., Landreth, G. E., Howell, G. R., Ransohoff, R. M., & Lamb, B. T. (2015). TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer\u2019s disease mouse models. Journal of Experimental Medicine, 212(3), 287\u2013295.","journal-title":"Journal of Experimental Medicine"},{"issue":"1","key":"8815_CR68","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s40478-021-01264-w","volume":"9","author":"A Jayaraman","year":"2021","unstructured":"Jayaraman, A., Htike, T. T., James, R., Picon, C., & Reynolds, R. (2021). TNF-mediated neuroinflammation is linked to neuronal necroptosis in Alzheimer\u2019s disease hippocampus. Acta Neuropathologica Communications, 9(1), 159.","journal-title":"Acta Neuropathologica Communications"},{"issue":"3","key":"8815_CR69","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s10753-018-0735-5","volume":"41","author":"T Jiang","year":"2018","unstructured":"Jiang, T., Zhang, Y.-D., Gao, Q., Ou, Z., Gong, P.-Y., Shi, J.-Q., Wu, L., & Zhou, J.-S. (2018). TREM2 ameliorates neuronal tau pathology through suppression of microglial inflammatory response. Inflammation, 41(3), 811\u2013823.","journal-title":"Inflammation"},{"key":"8815_CR70","doi-asserted-by":"crossref","unstructured":"Jun, G., Naj, A. C., Beecham, G. W., Wang, L.-S., Buros, J., Gallins, P. J., Buxbaum, J. D., Ertekin-Taner, N., Fallin, M. D., Friedland, R., Inzelberg, R., Kramer, P., Rogaeva, E., St. George-Hyslop, P., Arnold, S. E., Baldwin, C. T., Barber, R., Beach, T., Bigio, E. H., .., Alzheimer\u2019s Disease Genetics Consortium. (2010). Meta-analysis confirms CR1, CLU, and PICALM as Alzheimer disease risk loci and reveals interactions with APOE genotypes. Archives of Neurology, 67(12), 1473\u20131484.","DOI":"10.1001\/archneurol.2010.201"},{"issue":"4","key":"8815_CR71","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s10787-019-00580-x","volume":"27","author":"D Kaur","year":"2019","unstructured":"Kaur, D., Sharma, V., & Deshmukh, R. (2019). Activation of microglia and astrocytes: A roadway to neuroinflammation and Alzheimer\u2019s disease. Inflammopharmacology, 27(4), 663\u2013677.","journal-title":"Inflammopharmacology"},{"key":"8815_CR72","doi-asserted-by":"crossref","unstructured":"Kaur, S., K, M., Sharma, A., Giridharan, V. V., & Dandekar, M. P. (2024). Brain resident microglia in Alzheimer\u2019s disease: Foe or friends. Inflammopharmacology, 32(5), 2781\u20132800.","DOI":"10.1007\/s10787-024-01550-8"},{"issue":"11","key":"8815_CR73","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1039\/c5ib00158g","volume":"7","author":"DB Kell","year":"2015","unstructured":"Kell, D. B., & Pretorius, E. (2015). On the translocation of bacteria and their lipopolysaccharides between blood and peripheral locations in chronic, inflammatory diseases: The central roles of LPS and LPS-induced cell death. Integrative Biology (Cambridgr), 7(11), 1339\u20131377.","journal-title":"Integrative Biology (Cambridgr)"},{"issue":"10","key":"8815_CR74","doi-asserted-by":"publisher","first-page":"3969","DOI":"10.1093\/brain\/awad159","volume":"146","author":"KP Kepp","year":"2023","unstructured":"Kepp, K. P., Robakis, N. K., H\u00f8ilund-Carlsen, P. F., Sensi, S. L., & Vissel, B. (2023). The amyloid cascade hypothesis: An updated critical review. Brain, 146(10), 3969\u20133990.","journal-title":"Brain"},{"issue":"11","key":"8815_CR75","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12340","volume":"12","author":"B Kim","year":"2023","unstructured":"Kim, B., Kang, Y.-T., Mendelson, F. E., Hayes, J. M., Savelieff, M. G., Nagrath, S., & Feldman, E. L. (2023). Palmitate and glucose increase amyloid precursor protein in extracellular vesicles: Missing link between metabolic syndrome and Alzheimer\u2019s disease. Journal of Extracellular Vesicles, 12(11), e12340.","journal-title":"Journal of Extracellular Vesicles"},{"key":"8815_CR76","doi-asserted-by":"crossref","unstructured":"Kleinberger, G., Yamanishi, Y., Su\u00e1rez-Calvet, M., Czirr, E., Lohmann, E., Cuyvers, E., Struyfs, H., Pettkus, N., Wenninger-Weinzierl, A., Mazaheri, F., Tahirovic, S., Lle\u00f3, A., Alcolea, D., Fortea, J., Willem, M., Lammich, S., Molinuevo, J. L., S\u00e1nchez-Valle, R., Antonell, A., \u2026, Haass, C. (2014). TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis. Science Translational Medicine, 6(243), 243ra286.","DOI":"10.1126\/scitranslmed.3009093"},{"issue":"44","key":"8815_CR77","doi-asserted-by":"publisher","first-page":"9838","DOI":"10.1523\/JNEUROSCI.2557-04.2004","volume":"24","author":"J Koenigsknecht","year":"2004","unstructured":"Koenigsknecht, J., & Landreth, G. (2004). Microglial phagocytosis of fibrillar \u03b2-amyloid through a \u03b21 integrin-dependent mechanism. Journal of Neuroscience, 24(44), 9838\u20139846.","journal-title":"Journal of Neuroscience"},{"issue":"3","key":"8815_CR78","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00401-019-02103-y","volume":"139","author":"MJ Koper","year":"2020","unstructured":"Koper, M. J., Van Schoor, E., Ospitalieri, S., Vandenberghe, R., Vandenbulcke, M., von Arnim, C. A. F., Tousseyn, T., Balusu, S., De Strooper, B., & Thal, D. R. (2020). Necrosome complex detected in granulovacuolar degeneration is associated with neuronal loss in Alzheimer\u2019s disease. Acta Neuropathologica, 139(3), 463\u2013484.","journal-title":"Acta Neuropathologica"},{"issue":"5","key":"8815_CR79","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.1007\/s12035-021-02661-x","volume":"59","author":"B Kulkarni","year":"2022","unstructured":"Kulkarni, B., Cruz-Martins, N., & Kumar, D. (2022). Microglia in Alzheimer\u2019s disease: An unprecedented opportunity as prospective drug target. Molecular Neurobiology, 59(5), 2678\u20132693.","journal-title":"Molecular Neurobiology"},{"issue":"7","key":"8815_CR80","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s10495-023-01848-y","volume":"28","author":"S Kumari","year":"2023","unstructured":"Kumari, S., Dhapola, R., & Reddy, D. H. (2023). Apoptosis in Alzheimer\u2019s disease: Insight into the signaling pathways and therapeutic avenues. Apoptosis, 28(7), 943\u2013957.","journal-title":"Apoptosis"},{"issue":"1","key":"8815_CR81","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s40164-023-00464-5","volume":"12","author":"M Li","year":"2023","unstructured":"Li, M., Jiang, P., Yang, Y., Xiong, L., Wei, S., Wang, J., & Li, C. (2023). The role of pyroptosis and gasdermin family in tumor progression and immune microenvironment. Experimental Hematology & Oncology, 12(1), 103.","journal-title":"Experimental Hematology & Oncology"},{"issue":"2","key":"8815_CR82","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s40120-021-00282-z","volume":"10","author":"P Lin","year":"2021","unstructured":"Lin, P., Sun, J., Cheng, Q., Yang, Y., Cordato, D., & Gao, J. (2021). The development of pharmacological therapies for Alzheimer\u2019s disease. Neurology and Therapy, 10(2), 609\u2013626.","journal-title":"Neurology and Therapy"},{"issue":"1","key":"8815_CR83","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12964-023-01466-w","volume":"22","author":"J Liu","year":"2024","unstructured":"Liu, J., Zhou, J., Luan, Y., Li, X., Meng, X., Liao, W., Tang, J., & Wang, Z. (2024). cGAS-STING, inflammasomes and pyroptosis: An overview of crosstalk mechanism of activation and regulation. Cell Communication and Signaling: CCS, 22(1), 22.","journal-title":"Cell Communication and Signaling: CCS"},{"issue":"11","key":"8815_CR84","doi-asserted-by":"publisher","first-page":"4704","DOI":"10.1007\/s12035-020-02034-w","volume":"57","author":"M Liu","year":"2020","unstructured":"Liu, M., Sui, D., Dexheimer, T., Hovde, S., Deng, X., Wang, K.-W., Lin, H. L., Chien, H.-T., Kweon, H. K., Kuo, N. S., Ayoub, C. A., Jimenez-Harrison, D., Andrews, P. C., Kwok, R., Bochar, D. A., Kuret, J., Fortin, J., Tsay, Y.-G., & Kuo, M.-H. (2020). Hyperphosphorylation renders tau prone to aggregate and to cause cell death. Molecular Neurobiology, 57(11), 4704\u20134719.","journal-title":"Molecular Neurobiology"},{"key":"8815_CR85","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.888989","volume":"14","author":"H-Z Long","year":"2022","unstructured":"Long, H.-Z., Zhou, Z.-W., Cheng, Y., Luo, H.-Y., Li, F.-J., Xu, S.-G., & Gao, L.-C. (2022). The role of microglia in Alzheimer\u2019s disease from the perspective of immune inflammation and iron metabolism. Frontiers in Aging Neuroscience, 14, 888989.","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"1","key":"8815_CR86","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13024-021-00436-5","volume":"16","author":"L Magno","year":"2021","unstructured":"Magno, L., Bunney, T. D., Mead, E., Svensson, F., & Bictash, M. N. (2021). TREM2\/PLC\u03b32 signalling in immune cells: Function, structural insight, and potential therapeutic modulation. Molecular Neurodegeneration, 16(1), 22.","journal-title":"Molecular Neurodegeneration"},{"issue":"4","key":"8815_CR87","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1515\/revneuro-2021-0092","volume":"33","author":"S Mahdiabadi","year":"2022","unstructured":"Mahdiabadi, S., Momtazmanesh, S., Perry, G., & Rezaei, N. (2022). Immune modulations and immunotherapies for Alzheimer\u2019s disease: A comprehensive review. Reviews in the Neurosciences, 33(4), 365\u2013381.","journal-title":"Reviews in the Neurosciences"},{"issue":"7715","key":"8815_CR88","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1038\/d41586-018-05719-4","volume":"559","author":"S Makin","year":"2018","unstructured":"Makin, S. (2018). The amyloid hypothesis on trial. Nature, 559(7715), S4\u2013S7.","journal-title":"Nature"},{"issue":"24","key":"8815_CR89","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.3390\/cells12242824","volume":"12","author":"A Malvaso","year":"2023","unstructured":"Malvaso, A., Gatti, A., Negro, G., Calatozzolo, C., Medici, V., & Poloni, T. E. (2023). Microglial senescence and activation in healthy aging and Alzheimer\u2019s disease: Systematic review and neuropathological scoring. Cells, 12(24), 2824.","journal-title":"Cells"},{"issue":"7","key":"8815_CR90","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.15252\/embr.201743922","volume":"18","author":"F Mazaheri","year":"2017","unstructured":"Mazaheri, F., Snaidero, N., Kleinberger, G., Madore, C., Daria, A., Werner, G., Krasemann, S., Capell, A., Tr\u00fcmbach, D., Wurst, W., Brunner, B., Bultmann, S., Tahirovic, S., Kerschensteiner, M., Misgeld, T., Butovsky, O., & Haass, C. (2017). TREM2 deficiency impairs chemotaxis and microglial responses to neuronal injury. EMBO Reports, 18(7), 1186\u20131198.","journal-title":"EMBO Reports"},{"issue":"6","key":"8815_CR91","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0000536","volume":"2","author":"S Melov","year":"2007","unstructured":"Melov, S., Adlard, P. A., Morten, K., Johnson, F., Golden, T. R., Hinerfeld, D., Schilling, B., Mavros, C., Masters, C. L., Volitakis, I., Li, Q.-X., Laughton, K., Hubbard, A., Cherny, R. A., Gibson, B., & Bush, A. I. (2007). Mitochondrial oxidative stress causes hyperphosphorylation of tau. PLoS ONE, 2(6), e536.","journal-title":"PLoS ONE"},{"issue":"21","key":"8815_CR92","doi-asserted-by":"publisher","first-page":"12990","DOI":"10.3390\/ijms232112990","volume":"23","author":"S Merighi","year":"2022","unstructured":"Merighi, S., Nigro, M., Travagli, A., & Gessi, S. (2022). Microglia and Alzheimer\u2019s disease. International Journal of Molecular Sciences, 23(21), 12990.","journal-title":"International Journal of Molecular Sciences"},{"issue":"2","key":"8815_CR93","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3233\/JAD-170887","volume":"63","author":"P-F Meyer","year":"2018","unstructured":"Meyer, P.-F., Savard, M., Poirier, J., Labont\u00e9, A., Rosa-Neto, P., Weitz, T. M., Town, T., Breitner, J., The Alzheimer\u2019s Disease Neuroimaging Initiative Group, The Prevent- A. D. Research Group. (2018). Bi-directional association of cerebrospinal fluid immune markers with stage of Alzheimer\u2019s disease pathogenesis. Journal of Alzheimer\u2019s Disease, 63(2), 577\u2013590.","journal-title":"Journal of Alzheimer's Disease"},{"issue":"18","key":"8815_CR94","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa2100708","volume":"384","author":"MA Mintun","year":"2021","unstructured":"Mintun, M. A., Lo, A. C., Duggan Evans, C., Wessels, A. M., Ardayfio, P. A., Andersen, S. W., Shcherbinin, S., Sparks, J., Sims, J. R., Brys, M., Apostolova, L. G., Salloway, S. P., & Skovronsky, D. M. (2021). Donanemab in early Alzheimer\u2019s disease. New England Journal of Medicine, 384(18), 1691\u20131704.","journal-title":"New England Journal of Medicine"},{"key":"8815_CR95","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.617588","volume":"13","author":"A Misrani","year":"2021","unstructured":"Misrani, A., Tabassum, S., & Yang, L. (2021). Mitochondrial dysfunction and oxidative stress in Alzheimer\u2019s disease. Frontiers in Aging Neuroscience, 13, 617588.","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"2","key":"8815_CR96","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00401-022-02528-y","volume":"145","author":"S Moonen","year":"2023","unstructured":"Moonen, S., Koper, M. J., Van Schoor, E., Schaeverbeke, J. M., Vandenberghe, R., von Arnim, C. A. F., Tousseyn, T., De Strooper, B., & Thal, D. R. (2023). Pyroptosis in Alzheimer\u2019s disease: Cell type-specific activation in microglia, astrocytes and neurons. Acta Neuropathologica, 145(2), 175\u2013195.","journal-title":"Acta Neuropathologica"},{"key":"8815_CR97","first-page":"135","volume":"2","author":"GP Morris","year":"2014","unstructured":"Morris, G. P., Clark, I. A., & Vissel, B. (2014). Inconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer\u2019s disease. Acta Neuropathologica Communications, 2, 135.","journal-title":"Acta Neuropathologica Communications"},{"issue":"33","key":"8815_CR98","doi-asserted-by":"publisher","first-page":"6453","DOI":"10.1523\/JNEUROSCI.0521-22.2022","volume":"42","author":"P Mumford","year":"2022","unstructured":"Mumford, P., Tosh, J., Anderle, S., Gkanatsiou Wikberg, E., Lau, G., Noy, S., Cleverley, K., Saito, T., Saido, T. C., Yu, E., Brinkmalm, G., Portelius, E., Blennow, K., Zetterberg, H., Tybulewicz, V., Fisher, E. M. C., & Wiseman, F. K. (2022). Genetic mapping of APP and amyloid-\u03b2 biology modulation by trisomy 21. Journal of Neuroscience, 42(33), 6453\u20136468.","journal-title":"Journal of Neuroscience"},{"issue":"6765","key":"8815_CR99","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/47513","volume":"403","author":"T Nakagawa","year":"2000","unstructured":"Nakagawa, T., Zhu, H., Morishima, N., Li, E., Xu, J., Yankner, B. A., & Yuan, J. (2000). Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-\u03b2. Nature, 403(6765), 98\u2013103.","journal-title":"Nature"},{"key":"8815_CR100","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s13139-023-00837-y","volume":"58","author":"M-H Nam","year":"2024","unstructured":"Nam, M.-H., Na, H., Justin Lee, C., & Yun, M. (2024). A key mediator and imaging target in Alzheimer\u2019s disease: Unlocking the role of reactive astrogliosis through MAOB. Nuclear Medicine and Molecular Imaging, 58, 177\u2013184.","journal-title":"Nuclear Medicine and Molecular Imaging"},{"issue":"Pt 23","key":"8815_CR101","doi-asserted-by":"publisher","first-page":"4081","DOI":"10.1242\/jcs.019265","volume":"120","author":"RA Nixon","year":"2007","unstructured":"Nixon, R. A. (2007). Autophagy, amyloidogenesis and Alzheimer disease. Journal of Cell Science, 120(Pt 23), 4081\u20134091.","journal-title":"Journal of Cell Science"},{"key":"8815_CR102","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3389\/fneur.2013.00083","volume":"4","author":"W Noble","year":"2013","unstructured":"Noble, W., Hanger, D. P., Miller, C. C. J., & Lovestone, S. (2013). The importance of tau phosphorylation for neurodegenerative diseases. Frontiers in Neurology, 4, 83.","journal-title":"Frontiers in Neurology"},{"issue":"1","key":"8815_CR103","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13195-018-0436-1","volume":"10","author":"P Novak","year":"2018","unstructured":"Novak, P., Schmidt, R., Kontsekova, E., Kovacech, B., Smolek, T., Katina, S., Fialova, L., Prcina, M., Parrak, V., Dal-Bianco, P., Brunner, M., Staffen, W., Rainer, M., Ondrus, M., Ropele, S., Smisek, M., Sivak, R., Zilka, N., Winblad, B., & Novak, M. (2018). FUNDAMANT: An interventional 72-week phase 1 follow-up study of AADvac1, an active immunotherapy against tau protein pathology in Alzheimer\u2019s disease. Alzheimer\u2019s Research & Therapy, 10(1), 108.","journal-title":"Alzheimer\u2019s Research & Therapy"},{"issue":"1","key":"8815_CR104","doi-asserted-by":"publisher","first-page":"63","DOI":"10.14283\/jpad.2018.45","volume":"6","author":"P Novak","year":"2019","unstructured":"Novak, P., Zilka, N., Zilkova, M., Kovacech, B., Skrabana, R., Ondrus, M., Fialova, L., Kontsekova, E., Otto, M., & Novak, M. (2019). AADvac1, an active immunotherapy for Alzheimer\u2019s disease and non Alzheimer tauopathies: An overview of preclinical and clinical development. Journal of Prevention of Alzheimer\u2019s Disease, 6(1), 63\u201369.","journal-title":"Journal of Prevention of Alzheimer\u2019s Disease"},{"issue":"1","key":"8815_CR105","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40659-022-00404-3","volume":"55","author":"C Novoa","year":"2022","unstructured":"Novoa, C., Salazar, P., Cisternas, P., Gherardelli, C., Vera-Salazar, R., Zolezzi, J. M., & Inestrosa, N. C. (2022). Inflammation context in Alzheimer\u2019s disease, a relationship intricate to define. Biological Research, 55(1), 39.","journal-title":"Biological Research"},{"issue":"10","key":"8815_CR106","doi-asserted-by":"publisher","first-page":"5691","DOI":"10.1007\/s12035-023-03434-4","volume":"60","author":"MA Olesen","year":"2023","unstructured":"Olesen, M. A., & Quintanilla, R. A. (2023). Pathological impact of tau proteolytical process on neuronal and mitochondrial function: A crucial role in Alzheimer\u2019s disease. Molecular Neurobiology, 60(10), 5691\u20135707.","journal-title":"Molecular Neurobiology"},{"issue":"3","key":"8815_CR107","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/ana.25410","volume":"85","author":"F Panza","year":"2019","unstructured":"Panza, F., Lozupone, M., Seripa, D., & Imbimbo, B. P. (2019). Amyloid-\u03b2 immunotherapy for alzheimer disease: Is it now a long shot? Annals of Neurology, 85(3), 303\u2013315.","journal-title":"Annals of Neurology"},{"key":"8815_CR108","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1478-811X-9-19","volume":"9","author":"S Patergnani","year":"2011","unstructured":"Patergnani, S., Suski, J. M., Agnoletto, C., Bononi, A., Bonora, M., De Marchi, E., Giorgi, C., Marchi, S., Missiroli, S., Poletti, F., Rimessi, A., Duszynski, J., Wieckowski, M. R., & Pinton, P. (2011). Calcium signaling around mitochondria associated membranes (MAMs). Cell Communication and Signaling: CCS, 9, 19.","journal-title":"Cell Communication and Signaling: CCS"},{"issue":"5","key":"8815_CR109","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1007\/s12035-023-03217-x","volume":"60","author":"X Peng","year":"2023","unstructured":"Peng, X., Guo, H., Zhang, X., Yang, Z., Ruganzu, J. B., Yang, Z., Wu, X., Bi, W., Ji, S., & Yang, W. (2023). TREM2 inhibits tau hyperphosphorylation and neuronal apoptosis via the PI3K\/Akt\/GSK-3\u03b2 signaling pathway in vivo and in vitro. Molecular Neurobiology, 60(5), 2470\u20132485.","journal-title":"Molecular Neurobiology"},{"issue":"7","key":"8815_CR110","doi-asserted-by":"publisher","first-page":"E1659","DOI":"10.3390\/molecules25071659","volume":"25","author":"B Penke","year":"2020","unstructured":"Penke, B., Sz\u0171cs, M., & Bog\u00e1r, F. (2020). Oligomerization and conformational change turn monomeric \u03b2-amyloid and tau proteins toxic: Their role in Alzheimer\u2019s pathogenesis. Molecules, 25(7), E1659.","journal-title":"Molecules"},{"issue":"3","key":"8815_CR111","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1093\/brain\/awad005","volume":"146","author":"R Perneczky","year":"2023","unstructured":"Perneczky, R., Jessen, F., Grimmer, T., Levin, J., Fl\u00f6el, A., Peters, O., & Froelich, L. (2023). Anti-amyloid antibody therapies in Alzheimer\u2019s disease. Brain, 146(3), 842\u2013849.","journal-title":"Brain"},{"issue":"8","key":"8815_CR112","doi-asserted-by":"publisher","first-page":"E647","DOI":"10.3390\/antiox9080647","volume":"9","author":"A Picca","year":"2020","unstructured":"Picca, A., Calvani, R., Coelho-Junior, H. J., Landi, F., Bernabei, R., & Marzetti, E. (2020). Mitochondrial dysfunction, oxidative stress, and neuroinflammation: Intertwined roads to neurodegeneration. Antioxidants (Basel), 9(8), E647.","journal-title":"Antioxidants (Basel)"},{"issue":"1","key":"8815_CR113","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13024-021-00487-8","volume":"16","author":"P Preman","year":"2021","unstructured":"Preman, P., Tcw, J., Calafate, S., Snellinx, A., Alfonso-Triguero, M., Corthout, N., Munck, S., Thal, D. R., Goate, A. M., De Strooper, B., & Arranz, A. M. (2021). Human iPSC-derived astrocytes transplanted into the mouse brain undergo morphological changes in response to amyloid-\u03b2 plaques. Molecular Neurodegeneration, 16(1), 68.","journal-title":"Molecular Neurodegeneration"},{"issue":"2","key":"8815_CR114","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s12031-015-0498-5","volume":"56","author":"M-C Qian","year":"2015","unstructured":"Qian, M.-C., Liu, J., Yao, J.-S., Wang, W.-M., Yang, J.-H., Wei, L.-L., Shen, Y.-D., & Chen, W. (2015). Caspase-8 mediates amyloid-\u03b2-induced apoptosis in differentiated PC12 cells. Journal of Molecular Neuroscience, 56(2), 491\u2013499.","journal-title":"Journal of Molecular Neuroscience"},{"issue":"3","key":"8815_CR115","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3233\/JAD-2011-110326","volume":"26","author":"R Quiroz-Baez","year":"2011","unstructured":"Quiroz-Baez, R., Ferrera, P., Rosendo-Guti\u00e9rrez, R., Mor\u00e1n, J., Berm\u00fadez-Rattoni, F., & Arias, C. (2011). Caspase-12 activation is involved in amyloid-\u03b2 protein-induced synaptic toxicity. Journal of Alzheimer\u2019s Disease, 26(3), 467\u2013476.","journal-title":"Journal of Alzheimer's Disease"},{"issue":"1","key":"8815_CR116","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13024-021-00465-0","volume":"16","author":"MM Rahman","year":"2021","unstructured":"Rahman, M. M., & Lendel, C. (2021). Extracellular protein components of amyloid plaques and their roles in Alzheimer\u2019s disease pathology. Molecular Neurodegeneration, 16(1), 59.","journal-title":"Molecular Neurodegeneration"},{"issue":"12","key":"8815_CR117","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.3390\/cells11121885","volume":"11","author":"Y Rajesh","year":"2022","unstructured":"Rajesh, Y., & Kanneganti, T.-D. (2022). Innate immune cell death in neuroinflammation and Alzheimer\u2019s disease. Cells, 11(12), 1885.","journal-title":"Cells"},{"issue":"9","key":"8815_CR118","doi-asserted-by":"publisher","first-page":"6364","DOI":"10.1073\/pnas.092136199","volume":"99","author":"M Rapoport","year":"2002","unstructured":"Rapoport, M., Dawson, H. N., Binder, L. I., Vitek, M. P., & Ferreira, A. (2002). Tau is essential to beta-amyloid-induced neurotoxicity. Proceedings of the National Academy of Sciences of the United States of America, 99(9), 6364\u20136369.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"8815_CR119","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40478-024-01744-9","volume":"12","author":"L Rizzi","year":"2024","unstructured":"Rizzi, L., & Grinberg, L. T. (2024). Exploring the significance of caspase-cleaved tau in tauopathies and as a complementary pathology to phospho-tau in Alzheimer\u2019s disease: Implications for biomarker development and therapeutic targeting. Acta Neuropathologica Communications, 12(1), 36.","journal-title":"Acta Neuropathologica Communications"},{"issue":"5825","key":"8815_CR120","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1126\/science.1141736","volume":"316","author":"ED Roberson","year":"2007","unstructured":"Roberson, E. D., Scearce-Levie, K., Palop, J. J., Yan, F., Cheng, I. H., Wu, T., Gerstein, H., Yu, G.-Q., & Mucke, L. (2007). Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer\u2019s disease mouse model. Science, 316(5825), 750\u2013754.","journal-title":"Science"},{"issue":"2","key":"8815_CR121","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3390\/biom5020282","volume":"5","author":"HL Roberts","year":"2015","unstructured":"Roberts, H. L., & Brown, D. R. (2015). Seeking a mechanism for the toxicity of oligomeric \u03b1-synuclein. Biomolecules, 5(2), 282\u2013305.","journal-title":"Biomolecules"},{"issue":"1","key":"8815_CR122","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12974-021-02329-2","volume":"18","author":"W Rui","year":"2021","unstructured":"Rui, W., Xiao, H., Fan, Y., Ma, Z., Xiao, M., Li, S., & Shi, J. (2021). Systemic inflammasome activation and pyroptosis associate with the progression of amnestic mild cognitive impairment and Alzheimer\u2019s disease. Journal of Neuroinflammation, 18(1), 280.","journal-title":"Journal of Neuroinflammation"},{"issue":"19","key":"8815_CR123","doi-asserted-by":"publisher","first-page":"4582","DOI":"10.3390\/jcm10194582","volume":"10","author":"T Rujeedawa","year":"2021","unstructured":"Rujeedawa, T., Carrillo F\u00e9lez, E., Clare, I. C. H., Fortea, J., Strydom, A., Rebillat, A.-S., Coppus, A., Levin, J., & Zaman, S. H. (2021). The clinical and neuropathological features of sporadic (late-onset) and genetic forms of Alzheimer\u2019s disease. Journal of Clinical Medicine, 10(19), 4582.","journal-title":"Journal of Clinical Medicine"},{"issue":"1","key":"8815_CR124","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40478-022-01332-9","volume":"10","author":"N Salvadores","year":"2022","unstructured":"Salvadores, N., Moreno-Gonzalez, I., Gamez, N., Quiroz, G., Vegas-Gomez, L., Escand\u00f3n, M., Jimenez, S., Vitorica, J., Gutierrez, A., Soto, C., & Court, F. A. (2022). A\u03b2 oligomers trigger necroptosis-mediated neurodegeneration via microglia activation in Alzheimer\u2019s disease. Acta Neuropathologica Communications, 10(1), 31.","journal-title":"Acta Neuropathologica Communications"},{"key":"8815_CR125","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3389\/fcimb.2020.00238","volume":"10","author":"P Samir","year":"2020","unstructured":"Samir, P., Malireddi, R. K. S., & Kanneganti, T.-D. (2020). The panoptosome: A deadly protein complex driving pyroptosis, apoptosis, and necroptosis (PANoptosis). Frontiers in Cellular and Infection Microbiology, 10, 238.","journal-title":"Frontiers in Cellular and Infection Microbiology"},{"issue":"1","key":"8815_CR126","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13195-017-0279-1","volume":"9","author":"S Schedin-Weiss","year":"2017","unstructured":"Schedin-Weiss, S., Inoue, M., Hromadkova, L., Teranishi, Y., Yamamoto, N. G., Wiehager, B., Bogdanovic, N., Winblad, B., Sandebring-Matton, A., Frykman, S., & Tjernberg, L. O. (2017). Monoamine oxidase B is elevated in Alzheimer disease neurons, is associated with \u03b3-secretase and regulates neuronal amyloid \u03b2-peptide levels. Alzheimer\u2019s Research & Therapy, 9(1), 57.","journal-title":"Alzheimer\u2019s Research & Therapy"},{"key":"8815_CR127","doi-asserted-by":"crossref","unstructured":"Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., Kholodenko, D., Lee, M., Liao, Z., Lieberburg, I., Motter, R., Mutter, L., Soriano, F., Shopp, G., Vasquez, N., \u2026, Seubert, P. (1999). Immunization with amyloid-\u03b2 attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature, 400(6740), 173\u2013177.","DOI":"10.1038\/22124"},{"issue":"9","key":"8815_CR128","doi-asserted-by":"publisher","first-page":"4850","DOI":"10.3390\/ijms22094850","volume":"22","author":"C Sharma","year":"2021","unstructured":"Sharma, C., Kim, S., Nam, Y., Jung, U. J., & Kim, S. R. (2021a). Mitochondrial dysfunction as a driver of cognitive impairment in Alzheimer\u2019s disease. International Journal of Molecular Sciences, 22(9), 4850.","journal-title":"International Journal of Molecular Sciences"},{"issue":"12","key":"8815_CR129","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1007\/s11064-021-03418-7","volume":"46","author":"VK Sharma","year":"2021","unstructured":"Sharma, V. K., Singh, T. G., Singh, S., Garg, N., & Dhiman, S. (2021b). Apoptotic pathways and Alzheimer\u2019s disease: Probing therapeutic potential. Neurochemical Research, 46(12), 3103\u20133122.","journal-title":"Neurochemical Research"},{"key":"8815_CR130","doi-asserted-by":"publisher","first-page":"1191629","DOI":"10.3389\/fncel.2023.1191629","volume":"17","author":"R She","year":"2023","unstructured":"She, R., Liu, D., Liao, J., Wang, G., Ge, J., & Mei, Z. (2023). Mitochondrial dysfunctions induce PANoptosis and ferroptosis in cerebral ischemia\/reperfusion injury: From pathology to therapeutic potential. Frontiers in Cellular Neuroscience, 17, 1191629.","journal-title":"Frontiers in Cellular Neuroscience"},{"issue":"1","key":"8815_CR131","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40035-022-00292-3","volume":"11","author":"C Song","year":"2022","unstructured":"Song, C., Shi, J., Zhang, P., Zhang, Y., Xu, J., Zhao, L., Zhang, R., Wang, H., & Chen, H. (2022). Immunotherapy for Alzheimer\u2019s disease: Targeting \u03b2-amyloid and beyond. Translational Neurodegeneration, 11(1), 18.","journal-title":"Translational Neurodegeneration"},{"key":"8815_CR132","doi-asserted-by":"crossref","unstructured":"Su\u00e1rez-Calvet, M., Morenas-Rodr\u00edguez, E., Kleinberger, G., Schlepckow, K., Araque Caballero, M. \u00c1., Franzmeier, N., Capell, A., Fellerer, K., Nuscher, B., Eren, E., Levin, J., Deming, Y., Piccio, L., Karch, C. M., Cruchaga, C., Shaw, L. M., Trojanowski, J. Q., Weiner, M., Ewers, M., \u2026, Alzheimer\u2019s Disease Neuroimaging, I. (2019). Early increase of CSF sTREM2 in Alzheimer\u2019s disease is associated with tau related-neurodegeneration but not with amyloid-\u03b2 pathology. Molecular Neurodegeneration, 14(1), 1.","DOI":"10.1186\/s13024-018-0301-5"},{"issue":"1","key":"8815_CR133","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13195-021-00813-8","volume":"13","author":"CJ Swanson","year":"2021","unstructured":"Swanson, C. J., Zhang, Y., Dhadda, S., Wang, J., Kaplow, J., Lai, R. Y. K., Lannfelt, L., Bradley, H., Rabe, M., Koyama, A., Reyderman, L., Berry, D. A., Berry, S., Gordon, R., Kramer, L. D., & Cummings, J. L. (2021). A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer\u2019s disease with lecanemab, an anti-A\u03b2 protofibril antibody. Alzheimer\u2019s Research & Therapy, 13(1), 80.","journal-title":"Alzheimer's Research & Therapy"},{"key":"8815_CR134","doi-asserted-by":"crossref","unstructured":"Tanaka, H., Homma, H., Fujita, K., Kondo, K., Yamada, S., Jin, X., Waragai, M., Ohtomo, G., Iwata, A., Tagawa, K., Atsuta, N., Katsuno, M., Tomita, N., Furukawa, K., Saito, Y., Saito, T., Ichise, A., Shibata, S., Arai, H., \u2026, Okazawa, H. (2020). YAP-dependent necrosis occurs in early stages of Alzheimer\u2019s disease and regulates mouse model pathology. Nature Communications, 11(1), 507.","DOI":"10.1038\/s41467-020-14353-6"},{"issue":"1","key":"8815_CR135","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13041-016-0284-5","volume":"10","author":"D Tanokashira","year":"2017","unstructured":"Tanokashira, D., Mamada, N., Yamamoto, F., Taniguchi, K., Tamaoka, A., Lakshmana, M. K., & Araki, W. (2017). The neurotoxicity of amyloid \u03b2-protein oligomers is reversible in a primary neuron model. Molecular Brain, 10(1), 4.","journal-title":"Molecular Brain"},{"issue":"3","key":"8815_CR136","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1007\/s11010-021-04334-8","volume":"477","author":"AC Tecalco-Cruz","year":"2022","unstructured":"Tecalco-Cruz, A. C., Pedraza-Chaverri, J., Briones-Herrera, A., Cruz-Ramos, E., L\u00f3pez-Canovas, L., & Zepeda-Cervantes, J. (2022). Protein degradation-associated mechanisms that are affected in Alzheimer\u2019s disease. Molecular and Cellular Biochemistry, 477(3), 915\u2013925.","journal-title":"Molecular and Cellular Biochemistry"},{"issue":"8","key":"8815_CR137","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1001\/jamaneurol.2022.1375","volume":"79","author":"E Teng","year":"2022","unstructured":"Teng, E., Manser, P. T., Pickthorn, K., Brunstein, F., Blendstrup, M., Sanabria Bohorquez, S., Wildsmith, K. R., Toth, B., Dolton, M., Ramakrishnan, V., Bobbala, A., Sikkes, S. A. M., Ward, M., Fuji, R. N., Kerchner, G. A., & Tauriel, I. (2022). Safety and efficacy of semorinemab in individuals with prodromal to mild Alzheimer disease: A randomized clinical trial. JAMA Neurology, 79(8), 758\u2013767.","journal-title":"JAMA Neurology"},{"issue":"1","key":"8815_CR138","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10753-022-01721-1","volume":"46","author":"S Thakur","year":"2023","unstructured":"Thakur, S., Dhapola, R., Sarma, P., Medhi, B., & Reddy, D. H. (2023). Neuroinflammation in Alzheimer\u2019s disease: Current progress in molecular signaling and therapeutics. Inflammation, 46(1), 1\u201317.","journal-title":"Inflammation"},{"issue":"1","key":"8815_CR139","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13195-015-0125-2","volume":"7","author":"P Th\u00e9riault","year":"2015","unstructured":"Th\u00e9riault, P., ElAli, A., & Rivest, S. (2015). The dynamics of monocytes and microglia in Alzheimer\u2019s disease. Alzheimer\u2019s Research & Therapy, 7(1), 41.","journal-title":"Alzheimer's Research & Therapy"},{"issue":"8","key":"8815_CR140","doi-asserted-by":"publisher","first-page":"e72301","DOI":"10.1371\/journal.pone.0072301","volume":"8","author":"C Theunis","year":"2013","unstructured":"Theunis, C., Crespo-Biel, N., Gafner, V., Pihlgren, M., L\u00f3pez-Deber, M. P., Reis, P., Hickman, D. T., Adolfsson, O., Chuard, N., Ndao, D. M., Borghgraef, P., Devijver, H., Van Leuven, F., Pfeifer, A., & Muhs, A. (2013). Efficacy and safety of a liposome-based vaccine against protein Tau, assessed in tau.P301L mice that model tauopathy. PLoS ONE, 8(8), e72301.","journal-title":"PLoS ONE"},{"issue":"11","key":"8815_CR141","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/s41582-018-0072-1","volume":"14","author":"TK Ulland","year":"2018","unstructured":"Ulland, T. K., & Colonna, M. (2018). TREM2\u2014A key player in microglial biology and Alzheimer disease. Nature Reviews. Neurology, 14(11), 667\u2013675.","journal-title":"Nature Reviews. Neurology"},{"key":"8815_CR142","doi-asserted-by":"crossref","unstructured":"Usman, M. B., Bhardwaj, S., Roychoudhury, S., Kumar, D., Alexiou, A., Kumar, P., Ambasta, R. K., Prasher, P., Shukla, S., Upadhye, V., Khan, F. A., Awasthi, R., Shastri, M. D., Singh, S. K., Gupta, G., Chellappan, D. K., Dua, K., Jha, S. K., Ruokolainen, J., \u2026, Jha, N. K. (2021). Immunotherapy for Alzheimer\u2019s disease: Current scenario and future perspectives. Journal of Prevention of Alzheimer's Disease, 8(4), 534\u2013551.","DOI":"10.14283\/jpad.2021.52"},{"issue":"1","key":"8815_CR143","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41583-019-0240-3","volume":"21","author":"R van der Kant","year":"2020","unstructured":"van der Kant, R., Goldstein, L. S. B., & Ossenkoppele, R. (2020). Amyloid-\u03b2-independent regulators of tau pathology in Alzheimer disease. Nature Reviews. Neurology, 21(1), 21\u201335.","journal-title":"Nature Reviews. Neurology"},{"key":"8815_CR144","doi-asserted-by":"crossref","unstructured":"Vissers, M. F. J. M., Heuberger, J. A. A. C., Groeneveld, G. J., Oude Nijhuis, J., De Deyn, P. P., Hadi, S., Harris, J., Tsai, R. M., Cruz-Herranz, A., Huang, F., Tong, V., Erickson, R., Zhu, Y., Scearce-Levie, K., Hsiao-Nakamoto, J., Tang, X., Chang, M., Fox, B. M., Estrada, A. A., \u2026, Ho, C. (2022). Safety, pharmacokinetics and target engagement of novel RIPK1 inhibitor SAR443060 (DNL747) for neurodegenerative disorders: Randomized, placebo-controlled, double-blind phase I\/Ib studies in healthy subjects and patients. Clinical and Translational Science, 15(8), 2010\u20132023.","DOI":"10.1111\/cts.13317"},{"issue":"1","key":"8815_CR145","doi-asserted-by":"publisher","first-page":"13537","DOI":"10.1038\/s41598-017-13601-y","volume":"7","author":"NM Vogt","year":"2017","unstructured":"Vogt, N. M., Kerby, R. L., Dill-McFarland, K. A., Harding, S. J., Merluzzi, A. P., Johnson, S. C., Carlsson, C. M., Asthana, S., Zetterberg, H., Blennow, K., Bendlin, B. B., & Rey, F. E. (2017). Gut microbiome alterations in Alzheimer\u2019s disease. Science and Reports, 7(1), 13537.","journal-title":"Science and Reports"},{"key":"8815_CR146","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3389\/fncel.2015.00426","volume":"9","author":"R von Bernhardi","year":"2015","unstructured":"von Bernhardi, R., Cornejo, F., Parada, G. E., & Eugen\u00edn, J. (2015). Role of TGF\u03b2 signaling in the pathogenesis of Alzheimer\u2019s disease. Frontiers in Cellular Neuroscience, 9, 426.","journal-title":"Frontiers in Cellular Neuroscience"},{"issue":"9","key":"8815_CR147","doi-asserted-by":"publisher","first-page":"5155","DOI":"10.1007\/s12035-023-03387-8","volume":"60","author":"Z Waheed","year":"2023","unstructured":"Waheed, Z., Choudhary, J., Jatala, F. H., Fatimah, Noor, A., Zerr, I., & Zafar, S. (2023). The role of tau proteoforms in health and disease. Molecular Neurobiology, 60(9), 5155\u20135166.","journal-title":"Molecular Neurobiology"},{"issue":"5","key":"8815_CR148","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1111\/j.1471-4159.2006.04426.x","volume":"101","author":"DM Walsh","year":"2007","unstructured":"Walsh, D. M., & Selkoe, D. J. (2007). A\u03b2 oligomers\u2014A decade of discovery. Journal of Neurochemistry, 101(5), 1172\u20131184.","journal-title":"Journal of Neurochemistry"},{"issue":"2","key":"8815_CR149","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.trci.2017.03.005","volume":"3","author":"CY Wang","year":"2017","unstructured":"Wang, C. Y., Wang, P.-N., Chiu, M.-J., Finstad, C. L., Lin, F., Lynn, S., Tai, Y.-H., De Fang, X., Zhao, K., Hung, C.-H., Tseng, Y., Peng, W.-J., Wang, J., Yu, C.-C., Kuo, B.-S., & Frohna, P. A. (2017). UB-311, a novel UBITh\u00ae amyloid \u0392 peptide vaccine for mild Alzheimer\u2019s disease. Alzheimer\u2019s & Dementia (N Y), 3(2), 262\u2013272.","journal-title":"Alzheimer\u2019s & Dementia (N Y)"},{"issue":"12","key":"8815_CR150","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/s41419-023-06370-2","volume":"14","author":"L Wang","year":"2023","unstructured":"Wang, L., Zhu, Y., Zhang, L., Guo, L., Wang, X., Pan, Z., Jiang, X., Wu, F., & He, G. (2023). Mechanisms of PANoptosis and relevant small-molecule compounds for fighting diseases. Cell Death & Disease, 14(12), 851.","journal-title":"Cell Death & Disease"},{"issue":"10","key":"8815_CR151","first-page":"136","volume":"3","author":"W-Y Wang","year":"2015","unstructured":"Wang, W.-Y., Tan, M.-S., Yu, J.-T., & Tan, L. (2015a). Role of pro-inflammatory cytokines released from microglia in Alzheimer\u2019s disease. Annals of Translational Medicine, 3(10), 136.","journal-title":"Annals of Translational Medicine"},{"issue":"1","key":"8815_CR152","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13024-020-00376-6","volume":"15","author":"W Wang","year":"2020","unstructured":"Wang, W., Zhao, F., Ma, X., Perry, G., & Zhu, X. (2020). Mitochondria dysfunction in the pathogenesis of Alzheimer\u2019s disease: Recent advances. Molecular Neurodegeneration, 15(1), 30.","journal-title":"Molecular Neurodegeneration"},{"issue":"6","key":"8815_CR153","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.cell.2015.01.049","volume":"160","author":"Y Wang","year":"2015","unstructured":"Wang, Y., Cella, M., Mallinson, K., Ulrich, J. D., Young, K. L., Robinette, M. L., Gilfillan, S., Krishnan, G. M., Sudhakar, S., Zinselmeyer, B. H., Holtzman, D. M., Cirrito, J. R., & Colonna, M. (2015b). TREM2 lipid sensing sustains the microglial response in an Alzheimer\u2019s disease model. Cell, 160(6), 1061\u20131071.","journal-title":"Cell"},{"issue":"21","key":"8815_CR154","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.3390\/cells11213339","volume":"11","author":"SR Whittemore","year":"2022","unstructured":"Whittemore, S. R., Saraswat Ohri, S., Forston, M. D., Wei, G. Z., & Hetman, M. (2022). The proteostasis network: A global therapeutic target for neuroprotection after spinal cord injury. Cells, 11(21), 3339.","journal-title":"Cells"},{"key":"8815_CR155","unstructured":"WHO. (2024). Dementia. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dementia"},{"issue":"1","key":"8815_CR156","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s40035-021-00261-2","volume":"10","author":"HM Wilkins","year":"2021","unstructured":"Wilkins, H. M., & Swerdlow, R. H. (2021). Mitochondrial links between brain aging and Alzheimer\u2019s disease. Translational Neurodegeneration, 10(1), 33.","journal-title":"Translational Neurodegeneration"},{"issue":"7","key":"8815_CR157","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S1474-4422(12)70140-0","volume":"11","author":"B Winblad","year":"2012","unstructured":"Winblad, B., Andreasen, N., Minthon, L., Floesser, A., Imbert, G., Dumortier, T., Maguire, R. P., Blennow, K., Lundmark, J., Staufenbiel, M., Orgogozo, J.-M., & Graf, A. (2012). Safety, tolerability, and antibody response of active A\u03b2 immunotherapy with CAD106 in patients with Alzheimer\u2019s disease. The Lancet Neurology, 11(7), 597\u2013604.","journal-title":"The Lancet Neurology"},{"key":"8815_CR158","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101409","volume":"70","author":"K-M Wu","year":"2021","unstructured":"Wu, K.-M., Zhang, Y.-R., Huang, Y.-Y., Dong, Q., Tan, L., & Yu, J.-T. (2021a). The role of the immune system in Alzheimer\u2019s disease. Ageing Research Reviews, 70, 101409.","journal-title":"Ageing Research Reviews"},{"issue":"1","key":"8815_CR159","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s40035-021-00270-1","volume":"10","author":"M Wu","year":"2021","unstructured":"Wu, M., Zhang, M., Yin, X., Chen, K., Hu, Z., Zhou, Q., Cao, X., Chen, Z., & Liu, D. (2021b). The role of pathological tau in synaptic dysfunction in Alzheimer\u2019s diseases. Translational Neurodegeneration, 10(1), 45.","journal-title":"Translational Neurodegeneration"},{"issue":"9","key":"8815_CR160","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1007\/s11064-023-03945-5","volume":"48","author":"Z Wu","year":"2023","unstructured":"Wu, Z., Tang, W., Ibrahim, F. E. E. M., Chen, X., Yan, H., Tao, C., Wang, Z., Guo, Y., Fu, Y., Wang, Q., & Ge, Y. (2023). A\u03b2 induces neuroinflammation and microglial M1 polarization via cGAS-STING-IFITM3 signaling pathway in BV-2 cells. Neurochemical Research, 48(9), 2881\u20132894.","journal-title":"Neurochemical Research"},{"key":"8815_CR161","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3389\/fcell.2020.00595","volume":"8","author":"M Yang","year":"2020","unstructured":"Yang, M., Li, C., Yang, S., Xiao, Y., Xiong, X., Chen, W., Zhao, H., Zhang, Q., Han, Y., & Sun, L. (2020). Mitochondria-associated ER membranes\u2014The origin site of autophagy. Front Cell Dev Biol, 8, 595.","journal-title":"Front Cell Dev Biol"},{"issue":"8","key":"8815_CR162","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1007\/s12031-022-02002-0","volume":"72","author":"H Ye","year":"2022","unstructured":"Ye, H., Han, Y., Li, P., Su, Z., & Huang, Y. (2022). The role of post-translational modifications on the structure and function of tau protein. Journal of Molecular Neuroscience, 72(8), 1557\u20131571.","journal-title":"Journal of Molecular Neuroscience"},{"issue":"1","key":"8815_CR163","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/1471-2202-15-73","volume":"15","author":"W Yu","year":"2014","unstructured":"Yu, W., Bonnet, M., Farso, M., Ma, K., Chabot, J.-G., Martin, E., Torriglia, A., Guan, Z., McLaurin, J., Quirion, R., & Krantic, S. (2014). The expression of apoptosis inducing factor (AIF) is associated with aging-related cell death in the cortex but not in the hippocampus in the TgCRND8 mouse model of Alzheimer\u2019s disease. BMC Neuroscience, 15(1), 73.","journal-title":"BMC Neuroscience"},{"issue":"22","key":"8815_CR164","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1212\/WNL.0000000000003391","volume":"87","author":"X Zhan","year":"2016","unstructured":"Zhan, X., Stamova, B., Jin, L.-W., DeCarli, C., Phinney, B., & Sharp, F. R. (2016). Gram-negative bacterial molecules associate with Alzheimer disease pathology. Neurology, 87(22), 2324\u20132332.","journal-title":"Neurology"},{"issue":"9","key":"8815_CR165","doi-asserted-by":"publisher","first-page":"102942","DOI":"10.1016\/j.isci.2021.102942","volume":"24","author":"L Zhang","year":"2021","unstructured":"Zhang, L., Qian, Y., Li, J., Zhou, X., Xu, H., Yan, J., Xiang, J., Yuan, X., Sun, B., Sisodia, S. S., Jiang, Y.-H., Cao, X., Jing, N., & Lin, A. (2021). BAD-mediated neuronal apoptosis and neuroinflammation contribute to Alzheimer\u2019s disease pathology. iScience, 24(9), 102942.","journal-title":"iScience"},{"issue":"1","key":"8815_CR166","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s41392-023-01484-7","volume":"8","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y., Chen, H., Li, R., Sterling, K., & Song, W. (2023). Amyloid \u03b2-based therapy for Alzheimer\u2019s disease: Challenges, successes and future. Signal Transduction and Targeted Therapy, 8(1), 248.","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"11","key":"8815_CR167","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1007\/s11064-020-03121-z","volume":"45","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y., Zhao, Y., Zhang, J., & Yang, G. (2020). Mechanisms of NLRP3 inflammasome activation: Its role in the treatment of Alzheimer\u2019s disease. Neurochemical Research, 45(11), 2560\u20132572.","journal-title":"Neurochemical Research"},{"key":"8815_CR168","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40035-016-0054-4","volume":"5","author":"C Zheng","year":"2016","unstructured":"Zheng, C., Zhou, X.-W., & Wang, J.-Z. (2016). The dual roles of cytokines in Alzheimer\u2019s disease: Update on interleukins, TNF-\u03b1, TGF-\u03b2 and IFN-\u0393. Translational Neurodegeneration, 5, 7.","journal-title":"Translational Neurodegeneration"},{"key":"8815_CR169","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.711939","volume":"12","author":"X Zheng","year":"2021","unstructured":"Zheng, X., Chen, W., Gong, F., Chen, Y., & Chen, E. (2021). The role and mechanism of pyroptosis and potential therapeutic targets in sepsis: A review. Frontiers in Immunology, 12, 711939.","journal-title":"Frontiers in Immunology"},{"key":"8815_CR170","doi-asserted-by":"crossref","unstructured":"Zhong, L., Xu, Y., Zhuo, R., Wang, T., Wang, K., Huang, R., Wang, D., Gao, Y., Zhu, Y., Sheng, X., Chen, K., Wang, N., Zhu, L., Can, D., Marten, Y., Shinohara, M., Liu, C.-C., Du, D., Sun, H., \u2026, Chen, X.-F. (2019). Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer\u2019s disease model. Nature Communications, 10(1), 1365.","DOI":"10.1038\/s41467-019-09118-9"},{"key":"8815_CR171","doi-asserted-by":"publisher","first-page":"1120034","DOI":"10.3389\/fimmu.2023.1120034","volume":"14","author":"P Zhu","year":"2023","unstructured":"Zhu, P., Ke, Z.-R., Chen, J.-X., Li, S.-J., Ma, T.-L., & Fan, X.-L. (2023a). Advances in mechanism and regulation of PANoptosis: Prospects in disease treatment. Frontiers in Immunology, 14, 1120034.","journal-title":"Frontiers in Immunology"},{"issue":"5","key":"8815_CR172","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1007\/s10787-023-01291-0","volume":"31","author":"Y Zhu","year":"2023","unstructured":"Zhu, Y., Wang, Z., Gao, C., Zhang, L., & Sui, R. (2023b). Oxymatrine-mediated prevention of amyloid \u03b2-peptide-induced apoptosis on Alzheimer\u2019s model PC12 cells: In vitro cell culture studies and in vivo cognitive assessment in rats. Inflammopharmacology, 31(5), 2685\u20132699.","journal-title":"Inflammopharmacology"},{"issue":"1","key":"8815_CR173","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12974-023-02722-z","volume":"20","author":"M Zy\u015bk","year":"2023","unstructured":"Zy\u015bk, M., Beretta, C., Naia, L., Dakhel, A., P\u00e5v\u00e9nius, L., Brismar, H., Lindskog, M., Ankarcrona, M., & Erlandsson, A. (2023). Amyloid-\u03b2 accumulation in human astrocytes induces mitochondrial disruption and changed energy metabolism. Journal of Neuroinflammation, 20(1), 43.","journal-title":"Journal of Neuroinflammation"}],"container-title":["NeuroMolecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12017-024-08815-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12017-024-08815-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12017-024-08815-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T16:02:08Z","timestamp":1767196928000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12017-024-08815-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,29]]},"references-count":173,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8815"],"URL":"https:\/\/doi.org\/10.1007\/s12017-024-08815-z","relation":{},"ISSN":["1559-1174"],"issn-type":[{"value":"1559-1174","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,29]]},"assertion":[{"value":"15 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval and Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}],"article-number":"2"}}